FI763603A - - Google Patents

Info

Publication number
FI763603A
FI763603A FI763603A FI763603A FI763603A FI 763603 A FI763603 A FI 763603A FI 763603 A FI763603 A FI 763603A FI 763603 A FI763603 A FI 763603A FI 763603 A FI763603 A FI 763603A
Authority
FI
Finland
Application number
FI763603A
Other languages
Finnish (fi)
Other versions
FI63023C (fi
FI63023B (fi
Inventor
Maurice Prost
Original Assignee
Labaz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz filed Critical Labaz
Publication of FI763603A publication Critical patent/FI763603A/fi
Application granted granted Critical
Publication of FI63023B publication Critical patent/FI63023B/fi
Publication of FI63023C publication Critical patent/FI63023C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
FI763603A 1975-12-16 1976-12-15 Foerfarande foer framstaellning av smaertlindrande 4-amino-trans-dekahydrokinolinderivat FI63023C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5150775 1975-12-16
GB51507/75A GB1515540A (en) 1975-12-16 1975-12-16 4-amino-trans-decahydroquinoline derivatives

Publications (3)

Publication Number Publication Date
FI763603A true FI763603A (fr) 1977-06-17
FI63023B FI63023B (fi) 1982-12-31
FI63023C FI63023C (fi) 1983-04-11

Family

ID=10460296

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763603A FI63023C (fi) 1975-12-16 1976-12-15 Foerfarande foer framstaellning av smaertlindrande 4-amino-trans-dekahydrokinolinderivat

Country Status (28)

Country Link
JP (1) JPS6022711B2 (fr)
AR (1) AR214988A1 (fr)
AT (1) AT357535B (fr)
AU (1) AU509897B2 (fr)
BE (1) BE849431A (fr)
CA (1) CA1077040A (fr)
CH (1) CH618970A5 (fr)
DD (1) DD128709A5 (fr)
DE (1) DE2656678C2 (fr)
DK (1) DK564876A (fr)
ES (1) ES454285A1 (fr)
FI (1) FI63023C (fr)
FR (1) FR2335224A1 (fr)
GB (1) GB1515540A (fr)
HU (1) HU175391B (fr)
IE (1) IE44355B1 (fr)
IT (1) IT1065969B (fr)
MX (1) MX5798E (fr)
NL (1) NL7613629A (fr)
NO (1) NO145916C (fr)
NZ (1) NZ182758A (fr)
OA (1) OA05515A (fr)
PL (1) PL101143B1 (fr)
PT (1) PT65970B (fr)
SE (1) SE434396B (fr)
SU (1) SU633476A3 (fr)
YU (1) YU39980B (fr)
ZA (1) ZA767112B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2592879B1 (fr) * 1986-01-13 1988-04-29 Roussel Uclaf Nouveaux derives de la decahydroquinoleine, leur procede de preparation, les intermediaires de preparation, leur application a titre de medicaments et les compositions les renfermant
US20070208003A1 (en) * 2004-03-26 2007-09-06 Bell Michael G Compounds and methods for treating dyslipidemia

Also Published As

Publication number Publication date
AT357535B (de) 1980-07-10
HU175391B (hu) 1980-07-28
DK564876A (da) 1977-06-17
IE44355L (en) 1977-06-16
NL7613629A (nl) 1977-06-20
ES454285A1 (es) 1977-11-16
PT65970A (fr) 1977-01-01
JPS52102284A (en) 1977-08-27
DD128709A5 (de) 1977-12-07
IE44355B1 (en) 1981-11-04
NO145916B (no) 1982-03-15
JPS6022711B2 (ja) 1985-06-03
BE849431A (fr) 1977-06-15
CA1077040A (fr) 1980-05-06
AU509897B2 (en) 1980-05-29
DE2656678C2 (de) 1986-12-04
ATA932076A (de) 1979-12-15
SU633476A3 (ru) 1978-11-15
CH618970A5 (en) 1980-08-29
SE7614105L (sv) 1977-06-17
FI63023C (fi) 1983-04-11
NO764251L (fr) 1977-06-17
ZA767112B (en) 1978-07-26
FR2335224B1 (fr) 1980-03-14
DE2656678A1 (de) 1977-06-30
IT1065969B (it) 1985-03-04
YU39980B (en) 1985-06-30
YU307176A (en) 1982-08-31
OA05515A (fr) 1981-04-30
NZ182758A (en) 1979-03-28
FR2335224A1 (fr) 1977-07-15
PL101143B1 (pl) 1978-12-30
AR214988A1 (es) 1979-08-31
FI63023B (fi) 1982-12-31
NO145916C (no) 1982-06-23
GB1515540A (en) 1978-06-28
AU2032876A (en) 1978-06-15
SE434396B (sv) 1984-07-23
MX5798E (es) 1984-07-25
PT65970B (fr) 1978-06-16

Similar Documents

Publication Publication Date Title
CH596345A5 (fr)
FR2319464B3 (fr)
JPS5630102Y2 (fr)
FI763603A (fr)
CH606588A5 (fr)
BG22483A1 (fr)
BG22542A1 (fr)
BG22611A1 (fr)
BG22748A1 (fr)
BG22763A1 (fr)
BG23118A1 (fr)
CH576092A5 (fr)
CH585086A5 (fr)
CH586393A5 (fr)
CH587511B5 (fr)
CH589394A5 (fr)
CH592314A5 (fr)
CH592865A5 (fr)
CH593567A5 (fr)
CH594936A5 (fr)
CH595234A5 (fr)
CH595672A5 (fr)
CH596455A5 (fr)
CH596809A5 (fr)
CH596992A5 (fr)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANOFI